Home » Topics » Regulatory

Regulatory
RSS

FDA first to approve Anthim for inhalation anthrax

March 22, 2016

FDA approves Xalkori for ROS1-positive metastatic NSCLC

March 14, 2016

FDA approves Odefsey single-tablet regimen for HIV-1 infection

March 2, 2016

FDA approves Gazyva for use in follicular lymphoma

Feb. 29, 2016

Takeda's combination packs for H. pylori eradication approved in Japan

Feb. 26, 2016

FDA approves Ibrance for new metastatic breast cancer indication

Feb. 24, 2016

FDA approves Halaven in new indication

Jan. 29, 2016

FDA approves Merck & Co.'s Zepatier for HCV infection

Jan. 29, 2016

Expanded FDA approvals for Opdivo + Yervoy and single-agent Opdivo in melanoma

Jan. 25, 2016

UCB's Briviact approved in E.U. as adjunctive treatment for partial-onset seizures

Jan. 22, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...